Transtissue Technologies GmbH

Transtissue Technologies GmbH is an SME in Berlin, Germany that has taken part in 2 EU-funded projects since 2012, receiving €645k in EU funding.

EU funding received€645k
EU projects2
As coordinator0
Running now0
First EU project2012
Latest project2021
CountryGermany
EU registration (PIC)984642442
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Transtissue Technologies GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€341k · 1 project
  • FP7 (2007 to 2013)€304k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • INKplantPartner

    INK-BASED HYBRID MULTI-MATERIAL FABRICATION OF NEXT GENERATION IMPLANTS

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €341ktheir share
  • TissueGENPartner

    THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €304ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biomaterials
  • bioreactors
  • implants

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime